Position in BMY
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$15,188,401
-$52,337 QoQ
Shares Held
263,596
+4.9% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#317
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. BMY ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,188,401 | 263,596 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $15,240,738 | 251,290 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $10,180,581 | 188,739 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $7,474,964 | 165,742 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,026,035 | 151,783 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $7,736,276 | 126,845 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,652,002 | 135,290 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $6,831,490 | 132,035 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $3,028,326 | 72,919 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $3,417,954 | 63,027 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $4,544,680 | 88,573 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $3,472,184 | 59,824 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $6,530,637 | 102,121 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $6,824,609 | 98,465 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,163,287 | 16,168 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $995,899 | 14,009 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,685,761 | 21,893 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,370,188 | 46,148 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $314,368 | 5,042 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $426,852 | 7,214 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $526,942 | 7,886 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $410,913 | 6,509 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $373,606 | 6,023 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $300,786 | 4,989 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $236,611 | 4,365 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $228,422 | 4,098 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||